30.5.2017 08:02 | Business Wire
Mobidiag Extends Distribution Agreement with PerkinElmer to Offer Amplidiag® Diagnostics Products in African Countries and Israel
Mobidiag Ltd, a Finnish molecular diagnostics company, today announced the expansion of its distribution agreement with PerkinElmer’s Wallac Oy subsidiary to include distribution of the Amplidiag® product line in Israel and several countries in Africa. The Amplidiag® product line, including in vitro diagnostic tests and compatible systems for the detection of gastrointestinal infections, is now distributed in Botswana, Ghana, Ivory Coast, Kenya, Mauritius, Morocco, Mozambique, Nigeria, Rwanda, Senegal, Uganda and Israel.
“Since January 2017 Amplidiag’s product line has been available outside of Europe, and more specifically in South Africa through a distribution agreement with PerkinElmer. The relationship has been very successful since then and as a result we are extending the agreement to speed up our sales coverage in Africa and also to enter the Middle East diagnostics market. We are very pleased that PerkinElmer will continue to support us in our endeavor with its acknowledged expertise and worldwide leadership in the field of diagnostics,” said Tuomas Tenkanen, CEO at Mobidiag.
The agreement is effective immediately and covers all Amplidiag IVD tests (Amplidiag® H. pylori+ClariR, Amplidiag® Stool Parasites, Amplidiag® CarbaR+VRE, Amplidiag® C. difficile+027, Amplidiag® Bacterial GE and upcoming Amplidiag® Viral GE and Amplidiag® CarbaR+MCR) as well as the Amplidiag® Easy system.
About Amplidiag products
Amplidiag assays are innovative multiplex tests for the detection of gastrointestinal infections. They allow screening of panels of the most relevant gastrointestinal pathogens. Based on well-established real-time PCR technology, they ensure optimal performance, suitability for high-volume screening use and cost-effectiveness in mid-sized to large laboratory settings. In addition, Mobidiag allows process automation from sample extraction to PCR set-up with the Amplidiag Easy system.
About Mobidiag Ltd
Established in 2000, Mobidiag develops innovative solutions to advance the diagnosis of infectious diseases and serves the European clinical diagnostics market since 2008. Mobidiag is headquartered in Espoo, Finland.
Mobidiag addresses both high to medium volume screening with the new Amplidiag® Easy platform, bringing the Amplidiag suite further by automating the workflow from sample to results, and the upcoming Novodiag® platform & associated panels for a fully automated solution and suitable for smaller volumes and labs. Visit www.mobidiag.com .
Tuomas Tenkanen, +358 505534980
Information om Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco
Følg pressemeddelelser fra Business Wire
Ved at skrive dig op her, vil du modtage pressemeddelelser på mail når de udsendes. Indtast din mail og følg instruktionerne. Det er ligeså let at melde sig fra igen.
Flere pressemeddelelser fra Business Wire
SES27.6.2017 08:34 | pressemeddelelse
SES Restores Capacity from AMC-9 Satellite
GA-GLOBAL-PAYMENTS26.6.2017 22:52 | pressemeddelelse
Global Payments Expands Ecommerce and Omnichannel Offerings
NY-IFF26.6.2017 18:03 | pressemeddelelse
IFF Launches Tastepoint by IFF to Serve Dynamic Mid-Tier Customers, Accelerate Growth in North America
TX-ASCEND-PERFORMANCE26.6.2017 17:49 | pressemeddelelse
Ascend Performance Materials Establishes 40 Percent NTA-Na3 Liquid Production in Europe
SUMITOMO-SHI-FW26.6.2017 15:33 | pressemeddelelse
Sumitomo Heavy Industries, Ltd. Completes Share Acquisition of FW Energie B.V.
PHILIP-MORRIS-INTERNATIO26.6.2017 13:58 | pressemeddelelse
Philip Morris International Doubles Investment in Heated Tobacco Unit Facility in Italy. Another Step towards a Smoke-Free Future.
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum